Bispecific, tetravalent antigen binding proteins

Details for Australian Patent Application No. 2010262130 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Imhof-Jung, Sabine; Klein, Christian; Regula, Joerg Thomas; Schaefer, Wolfgang; Schanzer, Juergen Michael

Agent Griffith Hack

Pub. Number AU-A-2010262130

PCT Pub. Number WO2010/145793

Priority 09007966.6 18.06.09 EP

Filing date 14 June 2010

Wipo publication date 23 December 2010

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/145793 Priority application(s): WO2010/145793

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010262133-Biomarkers and methods for determining efficacy of anti-EGFR antibodies in cancer therapy

2010262129-Bispecific antigen binding proteins